‘Clinical trials a great opportunity for India’

Kiran Mazumdar Shaw.File PhotoK_MURALI_KUMAR

Kiran Mazumdar Shaw.File PhotoK_MURALI_KUMAR  

A job creator: Kiran Mazumdar-Shaw

Clinical trials present a great opportunity for India, but call for meticulous attention to detail, Biocon executive chairperson Kiran Mazumdar-Shaw said on Friday.

“It is a huge job creator, value driver and leads to innovation at the end of it,” she told a webinar organised by FICCI FLO, Hyderabad chapter. Stating that clinical trials can be on new molecules, drugs, or new therapies, and new regimens, she said that the country stood to benefit from the consequent creation of a strong experimental environment and ecosystem.

“I think what we need to focus on is the clinical research part. Today, we are talking about developing new vaccines. We need to do all of that in a very stringent research mode,” Ms. Shaw said. A release on the webinar said that FICCI president and joint MD of Apollo Hospitals Enterprises Sangita Reddy, and chairman and CEO-IKP Knowledge Park Deepanwita Chattopadhyay participated, while CEO of WE Hub Deepthi Ravula moderated.

Recommended for you